Published in Am J Pathol on October 29, 2010
FGFR4 role in epithelial-mesenchymal transition and its therapeutic value in colorectal cancer. PLoS One (2013) 0.97
A refined, rapid and reproducible high resolution melt (HRM)-based method suitable for quantification of global LINE-1 repetitive element methylation. BMC Res Notes (2011) 0.84
The breast cancer susceptibility gene product fibroblast growth factor receptor 2 serves as a scaffold for regulation of NF-κB signaling. Mol Cell Biol (2012) 0.84
Is fibroblast growth factor receptor 4 a suitable target of cancer therapy? Curr Pharm Des (2014) 0.80
A kinome-targeted RNAi-based screen links FGF signaling to H2AX phosphorylation in response to radiation. Cell Mol Life Sci (2015) 0.76
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature (2008) 8.38
Receptor specificity of the fibroblast growth factor family. J Biol Chem (1996) 7.58
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol (2007) 6.41
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol (2008) 3.49
A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene (2006) 3.21
Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res (2004) 2.05
Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J (1992) 2.00
A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor. J Biol Chem (1992) 1.97
Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues. J Histochem Cytochem (1997) 1.96
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. Cancer Res (2002) 1.95
Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models. J Clin Invest (2009) 1.83
Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer (1993) 1.63
Paths of FGFR-driven tumorigenesis. Cell Cycle (2009) 1.63
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. Oncogene (2000) 1.57
The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res (2008) 1.53
FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. J Clin Oncol (2006) 1.31
Retracted Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J Clin Invest (2002) 1.24
Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1. J Biol Chem (1994) 1.21
Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction. EMBO J (1992) 1.14
A single nucleotide change in the mouse genome accelerates breast cancer progression. Cancer Res (2010) 1.09
Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor. J Biol Chem (1993) 1.05
The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells. Oncogene (2009) 1.01
CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases. Oncogene (2006) 1.01
Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer. Mol Endocrinol (2009) 1.00
The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma. Exp Mol Pathol (2006) 1.00
Expression and transforming activity of a variant of the heparin-binding fibroblast growth factor receptor (flg) gene resulting from splicing of the alpha exon at an alternate 3'-acceptor site. Biochem Biophys Res Commun (1992) 0.99
bFGF and aFGF induce membrane ruffling in breast cancer cells but not in normal breast epithelial cells: FGFR-4 involvement. Biochem J (1995) 0.97
G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis. Br J Cancer (2004) 0.96
FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression. Cell Signal (2005) 0.95
Cooperation between fibroblast growth factor receptor-4 and ErbB2 in regulation of cyclin D1 translation. J Biol Chem (2004) 0.94
Identification of a novel alternative splicing of human FGF receptor 4: soluble-form splice variant expressed in human gastrointestinal epithelial cells. Biochem Biophys Res Commun (2000) 0.90
A soluble dominant negative fibroblast growth factor receptor 4 isoform in human MCF-7 breast cancer cells. Biochem Biophys Res Commun (2001) 0.90
Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: a mechanism underlying pituitary neoplasia. Mol Endocrinol (2004) 0.89
Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis. Br J Cancer (2007) 0.88
Retracted Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer. Am J Pathol (2010) 0.87
FGF receptor signaling at the crossroads of endocrine homeostasis and tumorigenesis. Horm Metab Res (2005) 0.84
Fibroblast growth factor receptor-4 splice variants cause deletion of a critical tyrosine. IUBMB Life (1999) 0.81
Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study. BMC Cancer (2009) 0.80
High-resolution oligonucleotide array comparative genomic hybridization study and methylation status of the RPS14 gene in de novo myelodysplastic syndromes. Cancer Genet Cytogenet (2010) 0.80
RFLPs in the fibroblast growth factor receptor-4 locus (FGFR4) in 5q33-qter. Nucleic Acids Res (1991) 0.76
The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity (2009) 7.69
The 2004 World Health Organization classification of pituitary tumors: what is new? Acta Neuropathol (2005) 6.43
Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer (2006) 3.83
The prevalence of pituitary adenomas: a systematic review. Cancer (2004) 2.98
Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer. J Immunother (2013) 2.80
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis. Thyroid (2009) 2.79
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid (2012) 2.71
Primary frozen section diagnosis by robotic microscopy and virtual slide telepathology: the University Health Network experience. Hum Pathol (2009) 2.54
Fracture resistance and histological findings of immature teeth treated with mineral trioxide aggregate. Dent Traumatol (2008) 2.50
Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas. Arch Pathol Lab Med (2014) 2.31
Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter. Am J Pathol (2003) 2.29
Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol (2008) 2.21
Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol (2004) 2.08
VA opsin-based photoreceptors in the hypothalamus of birds. Curr Biol (2009) 2.01
Impact of the time interval between MDCT imaging and surgery on the accuracy of identifying metastatic disease in patients with pancreatic cancer. AJR Am J Roentgenol (2015) 2.00
The pathogenesis of pituitary tumours. Nat Rev Cancer (2002) 1.96
Diagnosis and management of hyperprolactinemia. CMAJ (2003) 1.85
Retracted Intragastric exposure to titanium dioxide nanoparticles induced nephrotoxicity in mice, assessed by physiological and gene expression modifications. Part Fibre Toxicol (2013) 1.80
Thyroid calcification and its association with thyroid carcinoma. Head Neck (2002) 1.70
The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinoma. Ann Surg Oncol (2014) 1.58
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. Nat Genet (2013) 1.56
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer (2014) 1.55
The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res (2008) 1.53
Molecular mechanism of titanium dioxide nanoparticles-induced oxidative injury in the brain of mice. Chemosphere (2013) 1.51
EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer (2011) 1.50
Normal mitochondrial dynamics requires rhomboid-7 and affects Drosophila lifespan and neuronal function. Curr Biol (2006) 1.47
Derivation of a benchmark for freshwater ionic strength. Environ Toxicol Chem (2012) 1.46
The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes. Cell Metab (2013) 1.45
Pseudopheochromocytoma of pregnancy. Endocr Pract (2003) 1.45
Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol (2005) 1.41
Growth enhancement in suppressor of cytokine signaling 2 (SOCS-2)-deficient mice is dependent on signal transducer and activator of transcription 5b (STAT5b). Mol Endocrinol (2002) 1.39
The pathogenesis of pituitary tumors. Annu Rev Pathol (2009) 1.38
"Next-generation" pathology and laboratory medicine. Arch Pathol Lab Med (2011) 1.38
Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma. J Clin Endocrinol Metab (2008) 1.37
Tristetraprolin down-regulates interleukin-8 and vascular endothelial growth factor in malignant glioma cells. Cancer Res (2008) 1.36
Oxygen tension in the rabbit lens and vitreous before and after vitrectomy. Exp Eye Res (2004) 1.36
PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors. J Immunother (2015) 1.35
Phosphorylation of the mitotic regulator protein Hec1 by Nek2 kinase is essential for faithful chromosome segregation. J Biol Chem (2002) 1.34
An unusual twin-his arrangement in the pore of ammonia channels is essential for substrate conductance. J Biol Chem (2006) 1.33
Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. Carcinogenesis (2013) 1.33
Fibroblast growth factor receptors as molecular targets in thyroid carcinoma. Endocrinology (2004) 1.31
AACE Medical Guidelines for Clinical Practice for the diagnosis and treatment of acromegaly. Endocr Pract (2004) 1.27
Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res (2003) 1.26
The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr Rev (2006) 1.24
Retracted Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J Clin Invest (2002) 1.24
The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma. Am J Clin Oncol (2015) 1.23
Functional diversity of melanopsins and their global expression in the teleost retina. Cell Mol Life Sci (2011) 1.23
Differential expression of two distinct functional isoforms of melanopsin (Opn4) in the mammalian retina. J Neurosci (2009) 1.22
XB130, a novel adaptor protein, promotes thyroid tumor growth. Am J Pathol (2010) 1.21
Molecular epidemiology of measles viruses in China, 1995-2003. Virol J (2007) 1.20
Application of immunohistochemistry to thyroid neoplasms. Arch Pathol Lab Med (2008) 1.20
Carney complex with adrenal cortical carcinoma. J Clin Endocrinol Metab (2011) 1.19
Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine (2011) 1.19
Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis (2004) 1.18
Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation. Cancer Res (2009) 1.18
Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function. Cancer Res (2008) 1.17
Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression. Cancer Res (2007) 1.16
Severe acute respiratory syndrome-associated coronavirus in lung tissue. Emerg Infect Dis (2004) 1.16
Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest (2002) 1.15
Histone 2B (H2B) expression is confined to a proper NAD+/NADH redox status. J Biol Chem (2008) 1.15
The improvement of spinach growth by nano-anatase TiO2 treatment is related to nitrogen photoreduction. Biol Trace Elem Res (2007) 1.14
A high-throughput proteomic approach provides distinct signatures for thyroid cancer behavior. Clin Cancer Res (2011) 1.14
Intratumoral lymphatics and lymph node metastases in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg (2003) 1.14
Papillary thyroid carcinoma: an overview. Arch Pathol Lab Med (2006) 1.13
Overt immune dysfunction after Cushing's syndrome remission: a consecutive case series and review of the literature. J Clin Endocrinol Metab (2011) 1.13
Clinicopathological correlations in pituitary adenomas. Brain Pathol (2012) 1.12
The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS One (2009) 1.11
A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma. Cancer Chemother Pharmacol (2011) 1.09
Acromegaly: re-thinking the cancer risk. Rev Endocr Metab Disord (2008) 1.07
Development of novel tetravalent anti-CD20 antibodies with potent antitumor activity. Cancer Res (2008) 1.07
Correlation of biochemical parameters with single parathyroid adenoma weight and volume. Head Neck (2002) 1.07
Toxicological characteristics of nanoparticulate anatase titanium dioxide in mice. Biomaterials (2009) 1.06
Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma. J Clin Endocrinol Metab (2002) 1.06
Rubella virus genotypes in the People's Republic of China between 1979 and 2007: a shift in endemic viruses during the 2001 Rubella Epidemic. J Clin Microbiol (2010) 1.06
Mechanism of nano-anatase TiO2 on promoting photosynthetic carbon reaction of spinach: inducing complex of rubisco-rubisco activase. Biol Trace Elem Res (2006) 1.06
Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways. Am J Pathol (2002) 1.05
Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review. Thyroid (2010) 1.04
Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol (2011) 1.04
A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin. Blood (2007) 1.03
Effect of nano-TiO2 on photochemical reaction of chloroplasts of spinach. Biol Trace Elem Res (2005) 1.03
Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis. Thyroid (2007) 1.03
Mechanisms of disease: The pathogenesis of pituitary tumors. Nat Clin Pract Endocrinol Metab (2006) 1.02
Follicular variant papillary thyroid carcinoma arising in struma ovarii. Endocr Pathol (2007) 1.02
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. J Clin Endocrinol Metab (2005) 1.01